Azitra, Inc.
AMEX:AZTRBiotechnology
Healthcare
$1.53 +113.99%
+$0.82 today
- Market cap
- $92.72M
- Beta
- -1.04
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.64
52W Low $0.05High $2.13
Volume 146.25M
Average 11.12M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$11.22M
FY 2025 · Annual
Investing Cash Flow
-$182,909.00
FY 2025 · Annual
Financing Cash Flow
$8.92M
FY 2025 · Annual
-33.0% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (8.94M) | (10.68M) | (11.28M) | (8.97M) | (10.96M) |
| Depreciation & Amortization | 84.77K | 405.98K | 425.55K | 448.24K | 453.14K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 306.06K | 184.47K | 151.51K | 245.05K | 62.74K |
| Change in Working Capital | 646.35K | 310.76K | (753.43K) | (441.72K) | (797.23K) |
| Accounts Receivables | 194.17K | 66.67K | 42.73K | 133.15K | (39.4K) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 282.98K | 420.75K | (68.68K) | (140.54K) | 0 |
| Other Working Capital | 169.2K | (176.66K) | (727.48K) | (434.33K) | (757.83K) |
| Other Non-Cash Items | (164.86K) | 1.43M | 4.1M | (1.47M) | 12.58K |
| Operating Cash Flow | (8.07M) | (8.35M) | (7.36M) | (10.18M) | (11.22M) |
| Capital Expenditures | (652.28K) | (341.01K) | (318.26K) | (379.25K) | (186.06K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (206.14K) | (303.66K) | (291.72K) | (370.68K) | (158.7K) |
| Investing Cash Flow | (652.28K) | (336.76K) | (318.26K) | (379.25K) | (182.91K) |
| Debt Repayment | 984.39K | 4.35M | (7.39K) | (14.6K) | (16.06K) |
| Common Stock Issued | 0 | 0 | 5.99M | 13.35M | 9.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8.48K | (215.38K) | 0 | (18.38K) | (96.86K) |
| Financing Cash Flow | 992.86K | 4.13M | 5.98M | 13.32M | 8.92M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (7.73M) | (4.55M) | (1.7M) | 2.76M | (2.49M) |
| Free Cash Flow | (8.72M) | (8.69M) | (7.68M) | (10.56M) | (11.41M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$11.0M
+ D&A$453.1K
+ Stock-Based Comp$62.7K
+ Deferred Tax$0
- Working Capital-$797.2K
+ Other Non-Cash$12.6K
= Operating Cash Flow-$11.2M
- Capex-$186.1K
= Free Cash Flow-$11.4M
Analysis
FY2025 free cash flow is -$11.4M. FCF conversion is 104.2% of net income. Operating cash flow was -$11.2M, with capex of -$186.1K. The largest bridge item is Working Capital at -$797.2K.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Oct 26, 2026 | |
| 8-K | Current report | Oct 22, 2026 | |
| 8-K | Current report | Oct 1, 2026 | |
| 8-K | Current report | Sep 28, 2026 | |
| 424B5 | 424B5 filing | Sep 28, 2026 |
Does AZTR generate free cash flow?
Azitra, Inc. (AZTR) generated -$11.41M of free cash flow in fiscal 2025.
How much operating cash flow does AZTR produce?
Operating cash flow was -$11.22M, before capital expenditures of $186,062.00.
Continue the stock analysis
Jump to another research area for this company.